OBJECTIVES: We aimed to determine the severity and co-occurrence of established and potential paraneoplastic conditions in pancreatic cancer (weight loss, new onset diabetes, fatigue, and depression) and their relation to patient characteristics. METHODS: Using information from personal interviews with 510 cases and 463 controls, we obtained adjusted odds ratios for weight loss, long-term and new-onset diabetes, fatigue, and depression before diagnosis. Among cases, we investigated the extent to which these factors occurred together and the characteristics of those reporting them. RESULTS: The adjusted odds ratio for weight loss (>3% of usual weight) was 27.0 (95% confidence interval, 17.1-42.6). Severe weight loss was common (21% of cases lost >15%), and was more common in those previously obese. Diabetes was more common in cases and was strongly associated with weight loss (P < 0.0001). Diabetes in cases more often led to prescription of insulin, compared with controls.Fatigue and depression were significantly more common in cases than controls but not related to weight loss or diabetes. These conditions were not related to stage at diagnosis. CONCLUSIONS: Weight loss, often severe, and new-onset diabetes frequently occur together before diagnosis of pancreatic cancer. Fatigue and depression are also potential precursors of diagnosis.
OBJECTIVES: We aimed to determine the severity and co-occurrence of established and potential paraneoplastic conditions in pancreatic cancer (weight loss, new onset diabetes, fatigue, and depression) and their relation to patient characteristics. METHODS: Using information from personal interviews with 510 cases and 463 controls, we obtained adjusted odds ratios for weight loss, long-term and new-onset diabetes, fatigue, and depression before diagnosis. Among cases, we investigated the extent to which these factors occurred together and the characteristics of those reporting them. RESULTS: The adjusted odds ratio for weight loss (>3% of usual weight) was 27.0 (95% confidence interval, 17.1-42.6). Severe weight loss was common (21% of cases lost >15%), and was more common in those previously obese. Diabetes was more common in cases and was strongly associated with weight loss (P < 0.0001). Diabetes in cases more often led to prescription of insulin, compared with controls.Fatigue and depression were significantly more common in cases than controls but not related to weight loss or diabetes. These conditions were not related to stage at diagnosis. CONCLUSIONS:Weight loss, often severe, and new-onset diabetes frequently occur together before diagnosis of pancreatic cancer. Fatigue and depression are also potential precursors of diagnosis.
Authors: Johan Dahl; Heidi Ormstad; Hans Christian D Aass; Ulrik Fredrik Malt; Lil Träskman Bendz; Leiv Sandvik; Lena Brundin; Ole A Andreassen Journal: Psychoneuroendocrinology Date: 2014-04-06 Impact factor: 4.905
Authors: Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen Journal: Gastroenterology Date: 2007-10-26 Impact factor: 22.682
Authors: Paolo G Gobbi; Manuela Bergonzi; Mario Comelli; Lara Villano; Donatella Pozzoli; Alessandro Vanoli; Paolo Dionigi Journal: Cancer Epidemiol Date: 2013-01-29 Impact factor: 2.984
Authors: Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue Journal: Nature Date: 2010-10-28 Impact factor: 49.962
Authors: Victoria E Shaw; Brian Lane; Claire Jenkinson; Trevor Cox; William Greenhalf; Christopher M Halloran; Joseph Tang; Robert Sutton; John P Neoptolemos; Eithne Costello Journal: Mol Cancer Date: 2014-05-20 Impact factor: 27.401
Authors: Christie Y Jeon; Donghui Li; Sean Cleary; Rachael Stolzenberg-Solomon; Cristina Bosetti; Carlo La Vecchia; Miquel Porta; Adetunji T Toriola; Rayjean J Hung; Robert C Kurtz; Sara H Olson Journal: Pancreas Date: 2018-03 Impact factor: 3.327
Authors: Kevin P Shah; Katherine A Baugh; Lisa S Brubaker; George Van Buren; Nicole Villafane-Ferriol; Amy L McElhany; Sadde Mohamed; Eric J Silberfein; Cary Hsu; Nader N Massarweh; Hop S Tran Cao; Jose E Mendez-Reyes; William E Fisher Journal: J Surg Res Date: 2019-11-15 Impact factor: 2.192
Authors: Amethyst Saldia; Sara H Olson; Pamela Nunes; Xiaolin Liang; Marguerite L Samson; Erin Salo-Mullen; Vanessa Marcell; Zsofia K Stadler; Peter J Allen; Kenneth Offit; Robert C Kurtz Journal: Cancer Prev Res (Phila) Date: 2019-07-23
Authors: Laura Nemer; Somashekar G Krishna; Zarine K Shah; Darwin L Conwell; Zobeida Cruz-Monserrate; Mary Dillhoff; Denis C Guttridge; Alice Hinton; Andrei Manilchuk; Timothy M Pawlik; Carl R Schmidt; Erin E Talbert; Tanios Bekaii-Saab; Phil A Hart Journal: Pancreas Date: 2017-10 Impact factor: 3.327
Authors: Brian D Nicholson; William Hamilton; Jack O'Sullivan; Paul Aveyard; Fd Richard Hobbs Journal: Br J Gen Pract Date: 2018-04-09 Impact factor: 5.386
Authors: Molly E Schwalb; Stephanie A Smith-Warner; Jianrui Hou; Thomas E Rohan; Linda Snetselaar; Juhua Luo; Jeanine M Genkinger Journal: Am J Epidemiol Date: 2022-05-20 Impact factor: 5.363
Authors: Christie Y Jeon; Sungjin Kim; Yu-Chen Lin; Harvey A Risch; Mark O Goodarzi; Teryl K Nuckols; Stephen J Freedland; Stephen J Pandol; Joseph R Pisegna Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-11-02 Impact factor: 4.090
Authors: Barbara J Kenner; Suresh T Chari; Anirban Maitra; Sudhir Srivastava; Deborah F Cleeter; Vay Liang W Go; Laura J Rothschild; Ann E Goldberg Journal: Pancreas Date: 2016-09 Impact factor: 3.327